Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
12.57
-0.21 (-1.64%)
At close: Feb 18, 2026, 4:00 PM EST
12.58
+0.01 (0.08%)
After-hours: Feb 18, 2026, 5:53 PM EST
Biodesix Market Cap
Biodesix has a market cap or net worth of $100 million as of February 18, 2026. Its market cap has decreased by -33.26% in one year.
Market Cap
100.00M
Enterprise Value
161.45M
1-Year Change
-33.26%
Ranking
Category
Stock Price
$12.57
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $100.00M, a decrease of -70.27%. That is a compound annual growth rate of -20.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 101.67M | 87.94% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 757.50M |
| Fulgent Genetics | 715.00M |
| Myriad Genetics | 411.07M |
| Prenetics Global | 353.06M |
| Burning Rock Biotech | 305.13M |
| MDxHealth | 178.75M |
| Insight Molecular Diagnostics | 170.38M |
| FONAR | 121.54M |